Cargando…

New Perspectives on Cholesterol and Lipoprotein Metabolism

Detalles Bibliográficos
Autores principales:	De Geest, Bart, Mishra, Mudit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10379683/ https://www.ncbi.nlm.nih.gov/pubmed/37511058 http://dx.doi.org/10.3390/ijms241411298

Ejemplares similares

Impact of High-Density Lipoproteins on Sepsis
por: De Geest, Bart, et al.
Publicado: (2022)

High-Density Lipoprotein-Targeted Therapies for Heart Failure
por: Mishra, Mudit, et al.
Publicado: (2020)

HDL dysfunction, function, and heart failure
por: Mishra, Mudit, et al.
Publicado: (2019)

Increased Remnant Lipoproteins in Apo E Deficient Mice Induce Coronary Atherosclerosis following Transverse Aortic Constriction and Aggravate the Development of Pressure Overload-Induced Cardiac Hypertrophy and Heart Failure
por: Muthuramu, Ilayaraja, et al.
Publicado: (2022)

Cholesterol-Lowering Gene Therapy Prevents Heart Failure with Preserved Ejection Fraction in Obese Type 2 Diabetic Mice
por: Aboumsallem, Joseph Pierre, et al.
Publicado: (2019)

Cholesterol lowering attenuates pressure overload-induced heart failure in mice with mild hypercholesterolemia
por: Muthuramu, Ilayaraja, et al.
Publicado: (2019)

Role of Oxidative Stress in Heart Failure: Insights from Gene Transfer Studies
por: De Geest, Bart, et al.
Publicado: (2021)

Role of Oxidative Stress in Diabetic Cardiomyopathy
por: De Geest, Bart, et al.
Publicado: (2022)

Of statins and low-density lipoprotein cholesterol, “fats” and fiction
por: Unnikrishnan, Ambika Gopalakrishnan, et al.
Publicado: (2016)

The Role of Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure Management: The Continuing Challenge of Clinical Outcome Endpoints in Heart Failure Trials
por: Ji, Luxi, et al.
Publicado: (2023)

Is Non-High-Density Lipoprotein Cholesterol Evaluation Perfect? From the High-Density Lipoprotein Function Viewpoint
por: Otsuka, Toshiaki
Publicado: (2022)

ABCC6- a new player in cellular cholesterol and lipoprotein metabolism?
por: Kuzaj, Patricia, et al.
Publicado: (2014)

Current Status of Low-Density Lipoprotein Cholesterol and Cardiovascular Diseases in Japan
por: Sun, Wanlu, et al.
Publicado: (2023)

Knowledge Gap Regarding Low Density Lipoprotein-Cholesterol Levels in Koreans
por: Kim, Hyeon Chang
Publicado: (2012)

Physical Fitness and Development of High Non-High-Density Lipoprotein Cholesterol
por: Koba, Shinji
Publicado: (2018)

Administration of apo A-I (Milano) nanoparticles reverses pathological remodelling, cardiac dysfunction, and heart failure in a murine model of HFpEF associated with hypertension
por: Mishra, Mudit, et al.
Publicado: (2020)

What is the Cause of Continuous and Marked Increase of Japanese High Density Lipoprotein Cholesterol?
por: Ueshima, Hirotsugu
Publicado: (2023)

Possible Regulation of Platelets by Native and Modified Low Density Lipoprotein-Cholesterol Particles
por: Han, Ki Hoon
Publicado: (2012)

Low‐density lipoprotein cholesterol and stroke: How low should we go?
por: Lui, David TW, et al.
Publicado: (2020)

Low Density Lipoprotein Cholesterol Target Goal Attainment Rate in Korean Patients with Diabetes
por: Lee, Eun Hae, et al.
Publicado: (2011)

Risk assessment of metabolic syndrome in adolescents using the triglyceride/high-density lipoprotein cholesterol ratio and the total cholesterol/high-density lipoprotein cholesterol ratio
por: Chu, Shou-Yu, et al.
Publicado: (2019)

Assessing the Accuracy of Estimated Lipoprotein(a) Cholesterol and Lipoprotein(a)‐Free Low‐Density Lipoprotein Cholesterol
por: Zheng, Weili, et al.
Publicado: (2022)

High-density lipoprotein metabolism and reverse cholesterol transport: strategies for raising HDL cholesterol
por: Trajkovska, Katerina Tosheska, et al.
Publicado: (2017)

Reconstituted HDL (Milano) Treatment Efficaciously Reverses Heart Failure with Preserved Ejection Fraction in Mice
por: Mishra, Mudit, et al.
Publicado: (2018)

Effective Treatment of Diabetic Cardiomyopathy and Heart Failure with Reconstituted HDL (Milano) in Mice
por: Aboumsallem, Joseph Pierre, et al.
Publicado: (2019)

The role of free triiodothyronine in high-density lipoprotein cholesterol metabolism
por: Huang, Fang, et al.
Publicado: (2019)

Optimal Low-Density Lipoprotein Cholesterol Level for Primary Prevention in Koreans with Type 2 Diabetes Mellitus
por: Kim, Ji Yoon, et al.
Publicado: (2023)

Personalized Medicine beyond Low-Density Lipoprotein Cholesterol to Combat Residual Risk for Coronary Artery Disease
por: Tada, Hayato
Publicado: (2021)

To be Functional, or not to be Low in Cholesterol, that is the Clinical Concern when Evaluating Anti-Atherosclerotic Actions of High-Density Lipoproteins
por: Yoshida, Hiroshi
Publicado: (2021)

Special Issue on “Advances in Cholesterol and Lipid Metabolism”
por: Reiss, Allison B., et al.
Publicado: (2022)

Calculated low density lipoprotein cholesterol: Its relevance in Indian perspective
por: Kumar Nigam, Prabhat
Publicado: (2017)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
por: Katsiki, Niki, et al.
Publicado: (2023)

Longitudinal associations of high-density lipoprotein cholesterol or low-density lipoprotein cholesterol with metabolic syndrome in the Chinese population: a prospective cohort study
por: Wang, Xiao-rong, et al.
Publicado: (2018)

Difference in Serum Non-High-Density Lipoprotein Cholesterol Levels in terms of Sex, Age, and Physique in Children and Adolescents
por: Abe, Yuriko
Publicado: (2016)

Small-Dense Low-Density Lipoprotein Cholesterol: A Subclinical Marker for the Primary Prevention of Coronary Heart Disease
por: Kokubo, Yoshihiro, et al.
Publicado: (2020)

Low‐Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events
por: Willeit, Peter, et al.
Publicado: (2020)

SR-BI: Linking Cholesterol and Lipoprotein Metabolism with Breast and Prostate Cancer
por: Gutierrez-Pajares, Jorge L., et al.
Publicado: (2016)

Arachidonic acid is associated with dyslipidemia and cholesterol-related lipoprotein metabolism signatures
por: Li, Fan, et al.
Publicado: (2022)

Comparison of low-density lipoprotein cholesterol/high-density lipoprotein cholesterol and total cholesterol/high-density lipoprotein cholesterol for the prediction of thin-cap fibroatheroma determined by intravascular optical coherence tomography
por: WANG, Yao, et al.
Publicado: (2020)

Total cholesterol/high-density lipoprotein cholesterol and low-density lipoprotein cholesterol/high-density lipoprotein cholesterol as predictors of coronary artery calcification assessed by multidetector computed tomography coronary angiography
por: Elsadek Seaoud, Elshaimaa Aly M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e6lqhe7gr1ono45bot6u0p9mp3